Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27694172.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this review is to report on the value of <sup>11</sup>C-choline PET imaging as a diagnostic procedure for metastasis-directed therapies. Furthermore, the role of <sup>11</sup>C-choline PET/CT as a diagnostic tool for monitoring castration-resistant prostate cancer patients treated with systematic therapy is assessed. Finally, the role of <sup>11</sup>C-choline PET/CT in the prediction of survival in both castration-resistant prostate cancer patients and hormone-naïve patients is investigated.
Medical subject headings
- Choline
- Neoplasm Recurrence, Local
- Positron Emission Tomography Computed Tomography
- Prostatic Neoplasms